Natural Product: NPC267637

Natural Product IDNPC267637
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Anagalligenone-3-O-[Beta-D-Xylopyranosyl(1->2)-Beta-D-Glucopyranosyl(1->4)-Alpha-L-Arabinopyranoside]
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL2420027
PubChem CID 72375912
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey IYIIGIDPFTYYCU-ISLMCVPPSA-N
Standard InCHI InChI=1S/C46H74O17/c1-40(2)13-14-45-21-59-46(27(45)15-40)12-8-26-41(3)10-9-29(42(4,20-48)25(41)7-11-43(26,5)44(46,6)16-28(45)50)62-37-35(56)32(53)24(19-58-37)61-39-36(33(54)31(52)23(17-47)60-39)63-38-34(55)30(51)22(49)18-57-38/h22-27,29-39,47-49,51-56H,7-21H2,1-6H3/t22-,23-,24+,25-,26-,27-,29+,30+,31-,32+,33+,34-,35-,36-,37+,38+,39+,41+,42+,43-,44+,45-,46+/m1/s1
SMILES CC1(C)CC[C@@]23CO[C@@]4(CC[C@@H]5[C@@]6(C)CC[C@@H]([C@@](C)(CO)[C@@H]6CC[C@@]5(C)[C@]4(C)CC3=O)O[C@H]3[C@@H]([C@H]([C@H](CO3)O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)O[C@H]3[C@@H]([C@H]([C@@H](CO3)O)O)O)O)O)[C@@H]2C1

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   898.49 Volume:   873.961
?
Van der Waals volume.
Dense:   1.028 LogP:   1.082
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.931
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.724
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   8.0 Rigid Bonds:   48.0
TPSA:   263.75
?
Topological Polar Surface Area.
H-Bond Acceptor:   17.0
H-Bond Donor:   9.0 Rings:   9.0
Heavy Atoms:   17.0

MedChem Properties

QED Drug-Likeness Score:   0.148 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   7.598 Fsp3:   0.978
MCE-18:   251.67
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.927 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.002
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.007
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.158 Promiscuous compounds:   0.075

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.207 MDCK Permeability:   -5.235
Pgp-inhibitor:   0.0 Pgp-substrate:   0.193
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.006
20% Bioavailability (F20%):   0.148 30% Bioavailability (F30%):   0.286
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.892 MRP1:   0.049
Plasma Protein Binding (PPB):   75.999% Volume Distribution (VD):   -0.429
Fu: 15.577%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.806 BCRP inhibitor:   0.152
BSEP inhibitor:   0.005

ADMET: Metabolism

CYP1A2-inhibitor:   0.001 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.017 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.004 CYP3A4-substrate:   0.786
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.001
HLM stability:   0.056
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  0.216 Half-life (T1/2):  2.253

ADMET: Toxicity

hERG Blockers:  0.005 hERG Blockers (10um):  0.006
Human Hepatotoxicity (H-HT):  0.745 Drug-induced Liver Injury (DILI):  0.662
AMES Toxicity:  0.968 Rat Oral Acute Toxicity:  0.009
Maximum Recommended Daily Dose:  0.006 Skin Sensitization:  1.0
Carcinogencity:  0.174 Eye Corrosion:  0.0
Eye Irritation:  0.002 Respiratory Toxicity:  0.004
Drug-induced Neurotoxicity:  0.001 Ototoxicity:  0.996
Hematotoxicity:  0.731 Drug-induced Nephrotoxicity:  0.981
Genotoxicity:  0.174 RPMI-8226 Immunitoxicity:  0.175
A549 Cytotoxicity:  0.775 Hek293 Cytotoxicity:  0.444
BCF:   1.211
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.522
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.015
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.094
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33016 lysimachia parvifolia Species Primulaceae Eukaryota n.a. n.a. n.a. PMID[23911853]
NPO33016 lysimachia parvifolia Species Primulaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2015 Cell line U-266 Homo sapiens IC50 = 10370.0 nM PMID[16124784]
NPT116 Cell line HL-60 Homo sapiens IC50 = 10260.0 nM PMID[17008103]
NPT515 Cell line SGC-7901 Homo sapiens IC50 = 9240.0 nM PubChem BioAssay data set
NPT81 Cell line A549 Homo sapiens IC50 = 10880.0 nM PMID[16038541]
NPT65 Cell line HepG2 Homo sapiens IC50 = 8870.0 nM PMID[20970223]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 9140.0 nM PMID[23911853]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC267637 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8191 Intermediate Similarity NPC80640
0.7889 Intermediate Similarity NPC80417
0.7788 Intermediate Similarity NPC273189
0.7429 Intermediate Similarity NPC87393
0.7184 Intermediate Similarity NPC323231
0.7037 Intermediate Similarity NPC184805
0.6696 Remote Similarity NPC66513
0.6667 Remote Similarity NPC119628
0.6486 Remote Similarity NPC471373
0.633 Remote Similarity NPC171741
0.6281 Remote Similarity NPC471430
0.6228 Remote Similarity NPC475630
0.6174 Remote Similarity NPC471374
0.6106 Remote Similarity NPC77717
0.5877 Remote Similarity NPC158367
0.5826 Remote Similarity NPC470623
0.5785 Remote Similarity NPC470622
0.5678 Remote Similarity NPC138219
0.5678 Remote Similarity NPC475234
0.563 Remote Similarity NPC473688
0.563 Remote Similarity NPC471375
0.5583 Remote Similarity NPC51579
0.547 Remote Similarity NPC253611
0.547 Remote Similarity NPC488782
0.5455 Remote Similarity NPC209798
0.531 Remote Similarity NPC473130
0.5238 Remote Similarity NPC471425
0.5208 Remote Similarity NPC50658
0.5197 Remote Similarity NPC189575
0.5175 Remote Similarity NPC18724
0.5154 Remote Similarity NPC471426
0.5079 Remote Similarity NPC205129
0.5077 Remote Similarity NPC106701
0.5041 Remote Similarity NPC267238
0.5039 Remote Similarity NPC262567

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC267637 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data